Survival was significantly reduced with chronic anti-LTβR treatment (figure 2A), and dramatically different tumour frequencies were observed between livers from control and anti-LTβR-treated mice at day 40 (figure 2B). The gene discussed is LTBR; the disease is neoplasm.